Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-43
Closed -$4.58K 187
2023
Q1
$4.58K Hold
43
﹤0.01% 139
2022
Q4
$4.77K Buy
+43
New +$4.39K ﹤0.01% 119
2022
Q3
Sell
-50
Closed -$5K 155
2022
Q2
$5K Hold
50
0.01% 91
2022
Q1
$4K Sell
50
-950
-95% -$74.9K ﹤0.01% 115
2021
Q4
$77K Sell
1,000
-250
-20% -$19.9K 0.06% 55
2021
Q3
$94K Buy
+1,250
New +$95.1K 0.07% 60
2021
Q2
Sell
-1,462
Closed -$109K 144
2021
Q1
$109K Buy
+1,462
New +$108K 0.1% 59

Other funds holding MRK

Robbins Farley's MRK Position: Q2 2023 in Review

Robbins Farley sold out of Merck (MRK) in Q2 2023, closing a stake of 43 shares — an estimated $4.58K sold.

Robbins Farley first reported a position in MRK in Q1 2021 and held it in 7 quarters. The position peaked at $109K in Q1 2021. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Robbins Farley reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • Robbins Farley sold 43 Merck shares in Q2 2023, an estimated $4.58K.
  • Robbins Farley first reported a position in Merck in Q1 2021 and held it in 7 quarters.
  • Robbins Farley's Merck position peaked at $109K in Q1 2021.
  • 3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Robbins Farley's 13F filing for Q2 2023, filed 7 Aug 2023.